Identification of non-Alzheimer's disease tauopathies-related proteins by proteomic analysis

被引:9
作者
Yang, Guofeng [1 ,2 ]
Wang, Luning [1 ]
Zhu, Mingwei [1 ]
Xu, Dan [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Neurol, Beijing 100853, Peoples R China
[2] Hebei Med Univ, Affiliated Hosp 2, Dept Neurol, Shijiazhuang 050000, Peoples R China
关键词
MALDI-TOF/TOF tandem mass spectrometry; proteomics; two-dimensional gel electrophoresis; aging; brain;
D O I
10.1179/174313208X284124
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To identify differentially expressed proteins between tauopathies cases and controls and to explore molecular mechanisms of tauopathies. Method: Two-dimensional gel electrophoresis (2DE) was applied to separate the total proteins of temporal lobe obtained at autopsy from four tauopathies cases and four aged subjects without clinical or pathologic involvement of nervous system. The silver or Coomassie brilliant blue stained gels were analysed by 2-DE software Image Master 2D Elite. Selected differential protein spots were identified with MALDI-TOF/TOF tandem mass spectrometry. Results: Glyceraldehyde 3-phosphate dehydrogenase, uracil DNA glycosylase, human superoxide dismutase, isocitrate dehydrogenase subunit, synaptotagmin I, thioredoxin peroxidase 1, glial fibrillary acidic protein, P25 alpha, enoyl coenzyme A hydratase short chain 1, pyridoxine-5'- phosphate oxidase, Mn-superoxide dismutase and alpha enolase were significantly up-regulated in tauopathies brains, whereas antioxidant protein 2, ferritin heavy chain, glutamate dehydrogenase precursor, peptidyl-prolyl cis-trans isomerase A, serum albumin precursor and dihydropyrimidinase-related protein 2 were lowly expressed in tauopathies brains. Conclusions: We identified a number of tauopathy-related proteins that might be useful for discovering the molecular mechanisms of tauopathies, which could also be helpful for diagnosing and treating these disorders.
引用
收藏
页码:613 / 622
页数:10
相关论文
共 30 条
  • [1] Proteomic identification of nitrated proteins in Alzheimer's disease brain
    Castegna, A
    Thongboonkerd, V
    Klein, JB
    Lynn, B
    Markesbery, WR
    Butterfield, DA
    [J]. JOURNAL OF NEUROCHEMISTRY, 2003, 85 (06) : 1394 - 1401
  • [2] Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain.: Part II:: dihydropyrimidinase-related protein 2, α-enolase and heat shock cognate 71
    Castegna, A
    Aksenov, M
    Thongboonkerd, V
    Klein, JB
    Pierce, WM
    Booze, R
    Markesbery, WR
    Butterfield, DA
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 82 (06) : 1524 - 1532
  • [3] GENTRY NP, 1999, NATURE, V402, P615
  • [4] Görg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO
  • [5] 2-V
  • [6] Gulesserian T, 2001, J NEURAL TRANSM-SUPP, P71
  • [7] Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide
    Kesavapany, S
    Li, BS
    Amin, N
    Zheng, YL
    Grant, P
    Pant, HC
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1697 (1-2): : 143 - 153
  • [8] Age-related changes of Alzheimer's disease-associated proteins in cynomolgus monkey brains
    Kimura, N
    Tanemura, K
    Nakamura, S
    Takashima, A
    Ono, F
    Sakakibara, I
    Ishii, Y
    Kyuwa, S
    Yoshikawa, Y
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 310 (02) : 303 - 311
  • [9] Korolainen MA, 2002, ELECTROPHORESIS, V23, P3428, DOI 10.1002/1522-2683(200210)23:19<3428::AID-ELPS3428>3.0.CO
  • [10] 2-5